Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma

  1. Martin, T.G.
  2. Mateos, M.V.
  3. Nooka, A.
  4. Banerjee, A.
  5. Kobos, R.
  6. Pei, L.
  7. Qi, M.
  8. Verona, R.
  9. Doyle, M.
  10. Smit, J.
  11. Sun, W.
  12. Trancucci, D.
  13. Uhlar, C.
  14. van de Donk, N.W.C.J.
  15. Rodriguez, C.
Revue:
Cancer

ISSN: 1097-0142 0008-543X

Année de publication: 2023

Volumen: 129

Número: 13

Pages: 2035-2046

Type: Article

DOI: 10.1002/CNCR.34756 GOOGLE SCHOLAR lock_openAccès ouvert editor